Crossmark

Characterization of Metformin-Associated Metabolic Gene Expression Alterations in Type 2 Diabetes: Evidence from Patient Blood Samples and HepG2 Cells

Crossref DOI link: https://doi.org/10.1007/s44411-026-00671-6

Published Online: 2026-05-30

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Sari-Ak, Duygu

Çelik, Ayşe Büşranur

Al, Merve Nur

Helvaci-Kurt, Nazli

Kural, Alev

Senoymak, Mustafa Can

Erbatur, Nuriye Hale

Tutar, Merve

Zamocky, Marcel

Tutar, Yusuf
Funding

Funding for this research was provided by:

University of Health Sciences
License Information

Text and Data Mining valid from 2026-05-30

Version of Record valid from 2026-05-30
More Information

Article History

Received: 14 April 2026

Revised: 5 May 2026

Accepted: 17 May 2026

First Online: 30 May 2026

Declarations

:

: This study was approved by the Human Ethical Review Board of University of Health Sciences, (Registration number 15-2023; August 8, 2023) and was conducted in accordance with the principles of the Declaration of Helsinki and its amendments. All participants were thoroughly informed about the study and provided written informed consent.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below